Alina Solomon, MD, PhD, University of Eastern Finland, Kuopio, Finland, addresses the real-world implementation of the FINGER lifestyle interventions to prevent cognitive decline and progression to dementia. During the FINGER trials, participants received lifestyle interventions over 18 to 24 months within a carefully controlled scientific context, having their cognitive function assessed with a battery of neuropsychological tests. These interventions have shown the capacity to prevent cognitive decline, with the minimal criteria for prevention being approximately half the total trial duration and half of the interventions used in the trial. Dr Solomon emphasizes that these parameters are unique to the original FINGER trial and may differ dependent on the context. Replicating these controlled interventions in the real-world will be difficult, and it is likely that the implementation of them into healthcare systems will differ from country to country. This interview took place at the Alzheimer’s Association International Conference® (AAIC) 2023 in Amsterdam, Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
